For instance, miR-153 inhibits angiogenesis in breast cancer tissues by directly targeting HIF1α and angiopoietin (ANG1), thereby suppressing the migration and invasion of cancer cells (49). This evidence concerns the gene HIF1A and breast carcinoma.